Centiva Capital’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-100,000
Closed -$1.01M – 2167
2025
Q1
$1.01M Hold
100,000
– – 0.03% 491
2024
Q4
$1M Buy
+100,000
New +$1M 0.02% 522

Other funds holding TDACU

Centiva Capital's TDACU Position: Q2 2025 in Review

Centiva Capital sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 100,000 shares — an estimated $1.01M sold.

Centiva Capital first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $1.01M in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Centiva Capital reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 100,000 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $1.01M.
  • Centiva Capital first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Centiva Capital's Translational Development Acquisition Corp Units position peaked at $1.01M in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.